ABTD
ABBV icon

Arvest Bank Trust Division’s AbbVie ABBV Stock Holding History

Arvest Bank Trust Division’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Sell
60,049
-5,133
-8% -$1.1M 0.74% 34
2026
Q1 		$14.2M Sell
65,182
-1,139
-2% -$253K 0.77% 32
2025
Q4 		$15.2M Sell
66,321
-1,324
-2% -$302K 0.82% 32
2025
Q3 		$15.7M Sell
67,645
-27,326
-29% -$5.56M 0.87% 31
2025
Q2 		$17.6M Sell
94,971
-323
-0.3% -$60K 1.03% 27
2025
Q1 		$20M Buy
95,294
+5,900
+7% +$1.15M 1.26% 20
2024
Q4 		$15.9M Sell
89,394
-1,830
-2% -$336K 0.96% 33
2024
Q3 		$18M Buy
+91,224
New +$17M 1.04% 33
2021
Q3 		$9.96M Buy
92,315
+4,168
+5% +$476K 0.56% 54
2021
Q2 		$9.93M Buy
88,147
+2,164
+3% +$244K 0.55% 55
2021
Q1 		$9.3M Buy
85,983
+5,597
+7% +$599K 0.54% 51
2020
Q4 		$8.61M Buy
80,386
+7,237
+10% +$695K 0.54% 49
2020
Q3 		$6.41M Buy
73,149
+12,779
+21% +$1.2M 0.46% 49
2020
Q2 		$5.93M Sell
60,370
-38,255
-39% -$3.37M 0.44% 50
2020
Q1 		$7.51M Sell
98,625
-10,867
-10% -$926K 0.7% 48
2019
Q4 		$9.7M Sell
109,492
-3,082
-3% -$256K 0.62% 54
2019
Q3 		$8.52M Sell
112,574
-3,040
-3% -$208K 0.58% 55
2019
Q2 		$8.41M Sell
115,614
-2,489
-2% -$196K 0.57% 56
2019
Q1 		$9.52M Sell
118,103
-277
-0.2% -$22.7K 0.66% 54
2018
Q4 		$10.9M Sell
118,380
-785
-0.7% -$69K 0.87% 46
2018
Q3 		$11.3M Buy
119,165
+35,385
+42% +$3.36M 0.76% 54
2018
Q2 		$7.76M Sell
83,780
-590
-0.7% -$57.6K 0.55% 59
2018
Q1 		$7.99M Buy
+84,370
New +$9.27M 0.57% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Arvest Bank Trust Division's ABBV Position: Q2 2026 in Review

Arvest Bank Trust Division reduced its AbbVie (ABBV) stake by 7.9% in Q2 2026, selling an estimated $1.1M and leaving 60,049 shares worth $15.1M. The position accounts for 0.74% of the portfolio, ranked #34.

Arvest Bank Trust Division first reported a position in ABBV in Q1 2018 and has held it in 23 quarters since. The position peaked at $20M in Q1 2025. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Arvest Bank Trust Division held 60,049 shares of AbbVie worth $15.1M as of Q2 2026.
  • Arvest Bank Trust Division sold 5,133 AbbVie shares in Q2 2026, an estimated $1.1M.
  • AbbVie made up 0.74% of Arvest Bank Trust Division's portfolio in Q2 2026, its #34 holding.
  • Arvest Bank Trust Division first reported a position in AbbVie in Q1 2018 and has held it in 23 quarters since.
  • Arvest Bank Trust Division's AbbVie position peaked at $20M in Q1 2025.
  • 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Arvest Bank Trust Division's 13F filing for Q2 2026, filed 13 Aug 2026.